Literature DB >> 18419408

Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus.

Johnathan Storlie1, Lucie Maresova, Wallen Jackson, Charles Grose.   

Abstract

The complete DNA sequences of wild-type and vaccine strains of varicella-zoster virus have been published and listed in GenBank. In this comparative genomic analysis, the sequences of the 9 glycoprotein open reading frames (ORFs) were compared. They included gE (ORF68), gI (ORF 67), gC (ORF14), gH (ORF37), gL (ORF60), gB (ORF31), gK (ORF5), gM (ORF50), and gN (ORF8 or ORF9A). After realignment on the basis of newer data, the corrected gB sequence was lengthened to include 931 residues. The data showed that there were glycoprotein polymorphisms that differentiated North American/European strains from Japanese strains-for example, an additional ATG codon in the gL of all Oka strains. Also, there were a small number of coding single-nucleotide polymorphisms present only in glycoproteins of vaccine strains. Because these changes were highly conserved, the structure of the glycoprotein was unlikely to be altered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419408     DOI: 10.1086/522127

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction.

Authors:  Cindy Gutzeit; Martin J Raftery; Matthias Peiser; Karsten B Tischer; Martina Ulrich; Melanie Eberhardt; Eggert Stockfleth; Thomas Giese; Andreas Sauerbrei; Craig T Morita; Günther Schönrich
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

2.  Immunogenicity of varicella zoster virus glycoprotein E DNA vaccine.

Authors:  Lidao Bao; Guomin Wei; Hongmei Gan; Xianhua Ren; Ruilian Ma; Y I Wang; Haijun Lv
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

Review 3.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

4.  Variable Gene Expression in Human Ganglia Latently Infected with Varicella-Zoster Virus.

Authors:  Peter G E Kennedy; Paul Montague
Journal:  Viruses       Date:  2022-06-09       Impact factor: 5.818

5.  Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands.

Authors:  Alies van Lier; Albert Jan van Hoek; Wim Opstelten; Hein J Boot; Hester E de Melker
Journal:  BMC Health Serv Res       Date:  2010-08-13       Impact factor: 2.655

6.  Complete DNA sequences of two oka strain varicella-zoster virus genomes.

Authors:  Sueli L Tillieux; Wendy S Halsey; Elizabeth S Thomas; John J Voycik; Ganesh M Sathe; Ventzislav Vassilev
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

7.  Genome-wide reduction in transcriptomal profiles of varicella-zoster virus vaccine strains compared with parental Oka strain using long oligonucleotide microarrays.

Authors:  Esther Grinfeld; Alan Ross; Thorsten Forster; Peter Ghazal; Peter G E Kennedy
Journal:  Virus Genes       Date:  2008-11-27       Impact factor: 2.332

8.  Bioinformatics of varicella-zoster virus: single nucleotide polymorphisms define clades and attenuated vaccine genotypes.

Authors:  Vincent T Chow; Graham A Tipples; Charles Grose
Journal:  Infect Genet Evol       Date:  2012-11-24       Impact factor: 3.342

Review 9.  Varicella-Zoster Virus Infectious Cycle: ER Stress, Autophagic Flux, and Amphisome-Mediated Trafficking.

Authors:  Charles Grose; Erin M Buckingham; John E Carpenter; Jeremy P Kunkel
Journal:  Pathogens       Date:  2016-12-10

Review 10.  Molecular Aspects of Varicella-Zoster Virus Latency.

Authors:  Daniel P Depledge; Tomohiko Sadaoka; Werner J D Ouwendijk
Journal:  Viruses       Date:  2018-06-28       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.